Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nizatidine].

M Romero, M G Franzosi

    Medicina (Florence, Italy)
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Nizatidine, a potent H2-receptor antagonist, effectively suppresses nocturnal acid secretion. Clinical trials show it is comparable to ranitidine in healing ulcers and preventing relapse, with a good safety profile.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A photoexcited triplet state germylene with a half-life of hours at room temperature.

    Nature chemistry·2026
    Same author

    Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe.

    ESMO gastrointestinal oncology·2026
    Same author

    Proceedings: The Many Facets of Glucocorticoid Actions from Stress and Beyond.

    Poultry science·2026
    Same author

    CLINICAL EVIDENCE FROM A DERMATOLOGY CENTER ON THE TREATMENT OF VIRAL WARTS USING A 595 NM PULSED DYE LASER.

    Georgian medical news·2025
    Same author

    Synthesis and characterization of ceramic refractories based on industrial wastes.

    Scientific reports·2024
    Same author

    Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024

    Area of Science:

    • Pharmacology
    • Gastroenterology

    Background:

    • Nizatidine is a novel H2-receptor antagonist.
    • It exhibits potency similar to ranitidine.
    • Nizatidine does not impact hepatic metabolism and lacks anti-androgenic properties.

    Purpose of the Study:

    • To evaluate the efficacy and safety of nizatidine.
    • To assess its effect on nocturnal acid secretion.
    • To compare nizatidine with ranitidine in ulcer healing and relapse rates.

    Main Methods:

    • Administration of nizatidine at 300 mg in the evening or 150 mg at night.
    • Treatment durations up to eight weeks (300 mg) or one year (150 mg).
    • Evaluation of over 3800 patients for side effects, ulcer healing, and relapse rates.

    Related Experiment Videos

    Main Results:

    • A 300 mg evening dose effectively suppresses nocturnal acid secretion without diurnal effects.
    • No significantly unexpected or unwanted side effects were observed in over 3800 patients.
    • Healing rates for duodenal and gastric ulcers and relapse reduction are comparable to ranitidine.

    Conclusions:

    • Nizatidine is a potent H2-receptor antagonist with a favorable safety profile.
    • It offers comparable efficacy to ranitidine in treating peptic ulcers.
    • Its lack of hepatic and anti-androgenic effects makes it a valuable therapeutic option.